
Reversible male birth control injectable lasts 2 years, moves to phase 2 human trials
Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male contraceptive that conveniently blocks sperm for up to two years. Contraline reached a critical milestone in passing Phase I of …